Randomized Evaluation of COVID-19 Therapy
Condition: Severe Acute Respiratory Syndrome Interventions: Drug: Lopinavir-Ritonavir; Drug: Corticosteroid; Drug: Hydroxychloroquine; Drug: Azithromycin; Drug: Tocilizumab Sponsors: University of Oxford; UK Research and Innovation; National Institute for Health Research, United Kingdom; Wellcome; Bill and Melinda Gates Foundation; Department for International Development, United Kingdom; Health Data Research UK; Medical Research Council Popu lation Health Research Unit; NIHR Clinical Trials Unit Support Funding Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 11, 2020 Category: Research Source Type: clinical trials
INOVIO Expands Manufacturing of COVID-19 DNA Vaccine INO-4800 With New Funding from CEPI
PLYMOUTH MEETING, Pa., April 30, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced it has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH& Co. KG,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 30, 2020 Category: Pharmaceuticals Source Type: clinical trials
Sensory Analysis and Taste Modulation of Ketone Esters
Condition: Flavor Perception in Normal, Healthy Adults Intervention: Other: Flavor additive Sponsors: Monell Chemical Senses Center; HVMN (funding; holder of primary Department of Defense STTR contract) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials